SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies. It offers true single molecule sequencing (tSMS) platform, which offers a single molecule solution for DNA and RNA sequencing. The company has a collaboration agreement with Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. It serves academic and government institutions, hospitals and medical centers, pharmaceutical and biotechnology companies, and non-profit research organizations. The company was founded in 2013 and is based in Billerica, Massachusetts.
Earnings for SeqLL Inc. (SQL)
Earnings in 2022 (TTM): $-4,094,833
According to SeqLL Inc.'s latest financial reports the company's current earnings (TTM) are $-4,094,833. The earnings displayed on this page is the company's Pretax Income.
Earnings history of SeqLL Inc.
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2022 | $-4,094,833 | $-4,192,518 |
| 2021 | $-3,703,558 | $-3,906,078 |
| 2020 | $-1,045,353 | $-1,524,116 |
| 2019 | $-2,473,549 | $-2,655,799 |
| 2018 | $-2,888,017 | $-2,888,017 |
| 2017 | $-1,706,934 | $-1,706,934 |